267 related articles for article (PubMed ID: 22139797)
1. Vaspin in obesity and diabetes: pathophysiological and clinical significance.
Blüher M
Endocrine; 2012 Apr; 41(2):176-82. PubMed ID: 22139797
[TBL] [Abstract][Full Text] [Related]
2. Vaspin: a novel serpin with insulin-sensitizing effects.
Wada J
Expert Opin Investig Drugs; 2008 Mar; 17(3):327-33. PubMed ID: 18321232
[TBL] [Abstract][Full Text] [Related]
3. Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity.
Hida K; Wada J; Eguchi J; Zhang H; Baba M; Seida A; Hashimoto I; Okada T; Yasuhara A; Nakatsuka A; Shikata K; Hourai S; Futami J; Watanabe E; Matsuki Y; Hiramatsu R; Akagi S; Makino H; Kanwar YS
Proc Natl Acad Sci U S A; 2005 Jul; 102(30):10610-5. PubMed ID: 16030142
[TBL] [Abstract][Full Text] [Related]
4. Serum vaspin concentrations in human obesity and type 2 diabetes.
Youn BS; Klöting N; Kratzsch J; Lee N; Park JW; Song ES; Ruschke K; Oberbach A; Fasshauer M; Stumvoll M; Blüher M
Diabetes; 2008 Feb; 57(2):372-7. PubMed ID: 17991760
[TBL] [Abstract][Full Text] [Related]
5. Vaspin gene expression in human adipose tissue: association with obesity and type 2 diabetes.
Klöting N; Berndt J; Kralisch S; Kovacs P; Fasshauer M; Schön MR; Stumvoll M; Blüher M
Biochem Biophys Res Commun; 2006 Jan; 339(1):430-6. PubMed ID: 16298335
[TBL] [Abstract][Full Text] [Related]
6. Molecular Mechanisms of Vaspin Action - From Adipose Tissue to Skin and Bone, from Blood Vessels to the Brain.
Weiner J; Zieger K; Pippel J; Heiker JT
Adv Exp Med Biol; 2019; 1111():159-188. PubMed ID: 30051323
[TBL] [Abstract][Full Text] [Related]
7. [Vaspin and insulin resistance].
Wada J
Rinsho Byori; 2008 Aug; 56(8):705-11. PubMed ID: 18800627
[TBL] [Abstract][Full Text] [Related]
8. [Effect of different intensity exercise prescription on visceral adipose Vaspin gene, protein expression and plasma Vaspin concentration in aged obese rats].
Lin C; Bai Y; Sun M; Zhang H; Su M; Cui J; Song W; Wu L
Wei Sheng Yan Jiu; 2017 Jan; 46(1):70-77. PubMed ID: 29903155
[TBL] [Abstract][Full Text] [Related]
9. Vaspin inhibits kallikrein 7 by serpin mechanism.
Heiker JT; Klöting N; Kovacs P; Kuettner EB; Sträter N; Schultz S; Kern M; Stumvoll M; Blüher M; Beck-Sickinger AG
Cell Mol Life Sci; 2013 Jul; 70(14):2569-83. PubMed ID: 23370777
[TBL] [Abstract][Full Text] [Related]
10. Vaspin gene in rat adipose tissue: relation to obesity-induced insulin resistance.
Shaker OG; Sadik NA
Mol Cell Biochem; 2013 Jan; 373(1-2):229-39. PubMed ID: 23135683
[TBL] [Abstract][Full Text] [Related]
11. Role of Omentin, Vaspin, Cardiotrophin-1, TWEAK and NOV/CCN3 in Obesity and Diabetes Development.
Escoté X; Gómez-Zorita S; López-Yoldi M; Milton-Laskibar I; Fernández-Quintela A; Martínez JA; Moreno-Aliaga MJ; Portillo MP
Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28809783
[TBL] [Abstract][Full Text] [Related]
12. A novel adipocytokine, visceral adipose tissue-derived serine protease inhibitor (vaspin), and obesity.
Li Q; Chen R; Moriya J; Yamakawa J; Sumino H; Kanda T; Takahashi T
J Int Med Res; 2008; 36(4):625-9. PubMed ID: 18652756
[TBL] [Abstract][Full Text] [Related]
13. Overexpressing high levels of human vaspin limits high fat diet-induced obesity and enhances energy expenditure in a transgenic mouse.
Rapöhn I; Elias I; Weiner J; Pujol A; Kehr S; Chadt A; Al-Hasani H; Burkhardt R; Klöting N; Stumvoll M; Bosch F; Kovacs P; Heiker JT; Breitfeld J
Front Endocrinol (Lausanne); 2023; 14():1146454. PubMed ID: 37152954
[TBL] [Abstract][Full Text] [Related]
14. Vaspin (serpinA12) in obesity, insulin resistance, and inflammation.
Heiker JT
J Pept Sci; 2014 May; 20(5):299-306. PubMed ID: 24596079
[TBL] [Abstract][Full Text] [Related]
15. Calorie control increased vaspin levels of serum and periepididymal adipose tissue in diet-induced obese rats in association with serum free fatty acid and tumor necrosis factor alpha.
Wang YM; Wang WP; Wang LP; Lü QH; Zhou XH
Chin Med J (Engl); 2010 Apr; 123(7):936-41. PubMed ID: 20497691
[TBL] [Abstract][Full Text] [Related]
16. Review: Vaspin (SERPINA12) Expression and Function in Endocrine Cells.
Kurowska P; Mlyczyńska E; Dawid M; Jurek M; Klimczyk D; Dupont J; Rak A
Cells; 2021 Jul; 10(7):. PubMed ID: 34359881
[TBL] [Abstract][Full Text] [Related]
17. Effects of weight reduction on serum vaspin concentrations in obese subjects: modification by insulin resistance.
Chang HM; Lee HJ; Park HS; Kang JH; Kim KS; Song YS; Jang YJ
Obesity (Silver Spring); 2010 Nov; 18(11):2105-10. PubMed ID: 20339362
[TBL] [Abstract][Full Text] [Related]
18. Higher vaspin levels in subjects with obesity and type 2 diabetes mellitus: a meta-analysis.
Feng R; Li Y; Wang C; Luo C; Liu L; Chuo F; Li Q; Sun C
Diabetes Res Clin Pract; 2014 Oct; 106(1):88-94. PubMed ID: 25151227
[TBL] [Abstract][Full Text] [Related]
19. Bezafibrate on lipids and glucose metabolism in obese diabetic Otsuka Long-Evans Tokushima fatty rats.
Jia D; Yamamoto M; Otani M; Otsuki M
Metabolism; 2004 Apr; 53(4):405-13. PubMed ID: 15045684
[TBL] [Abstract][Full Text] [Related]
20. Central vaspin administration acutely reduces food intake and has sustained blood glucose-lowering effects.
Klöting N; Kovacs P; Kern M; Heiker JT; Fasshauer M; Schön MR; Stumvoll M; Beck-Sickinger AG; Blüher M
Diabetologia; 2011 Jul; 54(7):1819-23. PubMed ID: 21465327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
